Abstract | BACKGROUND: METHODS: Fourteen of 1236 patients referred for thyroid nodules had increased serum CT >10 pg/mL. A stimulation test with pentagastrin was done and both CT and PCT were measured after stimulation. All patients underwent thyroid ultrasound, fine-needle cytology and, if indicated, surgery with histological and immunohistochemical examination of the surgical specimens. RESULTS: After follow-up, two MTCs were found. These two patients had basal CT >100 pg/mL and detectable (>0.1 ng/mL) PCT, with 100% sensitivity. Pentagastrin stimulated CT achieved values above 100 pg/mL in two MTCs and in other two cases with no MTC outcome (50% PPV and 83% NPV). On the contrary, all patients with no MTC had both basal and stimulated undetectable PCT (100% PPV and 100% NPV). CONCLUSIONS: The addition of basal PCT measurement in patients with thyroid nodule(s) and increased CT may significantly improve accuracy of CT measurement without needing a PG stimulation test.
|
Authors | Luca Giovanella, Frederik A Verburg, Mauro Imperiali, Stefano Valabrega, Pierpaolo Trimboli, Luca Ceriani |
Journal | Clinical chemistry and laboratory medicine
(Clin Chem Lab Med)
Vol. 51
Issue 7
Pg. 1477-81
(Jul 2013)
ISSN: 1437-4331 [Electronic] Germany |
PMID | 23314540
(Publication Type: Journal Article)
|
Chemical References |
- Biomarkers, Tumor
- CALCA protein, human
- Protein Precursors
- Calcitonin
- Pentagastrin
- Calcitonin Gene-Related Peptide
|
Topics |
- Adult
- Aged
- Biomarkers, Tumor
(blood)
- Biopsy, Fine-Needle
- Calcitonin
(blood)
- Calcitonin Gene-Related Peptide
- Carcinoma, Neuroendocrine
- Female
- Humans
- Male
- Middle Aged
- Pentagastrin
(administration & dosage)
- Predictive Value of Tests
- Protein Precursors
(blood)
- Thyroid Gland
(diagnostic imaging, pathology)
- Thyroid Neoplasms
(blood, diagnosis, diagnostic imaging)
- Thyroid Nodule
(blood, diagnosis, diagnostic imaging)
- Ultrasonography
|